Vertex Pharma (VRTX) Tops Q3 EPS by 7c
Tweet
Share
E-mail
Get Alerts VRTX Hot Sheet
Price: $514.56 -1.26%
EPS Growth %: 0.0%
Financial Fact:
Royalty revenues: 3.84M
Today's EPS Names:
VIVO, BIOX, PMCB, More
EPS Growth %: 0.0%
Financial Fact:
Royalty revenues: 3.84M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Vertex Pharma (NASDAQ: VRTX) reported Q3 EPS of $1.09, $0.07 better than the analyst estimate of $1.02. Revenue for the quarter came in at $783.9 million versus the consensus estimate of $790.91 million.
For earnings history and earnings-related data on Vertex Pharma (VRTX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Oracle (ORCL) Tops Q1 EPS by 19c, Beats on Revenue; Beats on Cloud Revenue, Offers Q3 EPS Guidance
- Adobe Systems (ADBE) Tops Q3 EPS by 6c, Offers Guidance
- Frequency Electronics (FEIM) Tops Q1 EPS by 12c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
